Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer

Journal of Pathology

Volumn 188, Issue 1, 1999, Pages 44-50

  Wagner, Urs ^a   Süess, Katrin ^a   Luginbühl, Thomas ^a   Schmid, Ulrico ^b   Ackermann, Daniel ^b   Zellweger, Tobias ^b   Maurer, Robert ^c   Alund, Göran ^c   Knönagel, Hartmut ^d   Rist, Marcus ^e   Jordan, Paul ^a   Moch, Holger ^a   Mihatsch, Michael J ^a   Gasser, Thomas C ^a   Sauter, Guido ^a,f  

^a UNIVERSITY OF BASEL   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

^d Spital Limmattal   (Switzerland)

^e Clara Hospital   (Switzerland)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Bladder neoplasms; Cyclin D1; Ki67 LI; Prognosis; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CYCLIN D1; DOXORUBICIN; EPIRUBICIN; ETRETINATE; FENORUBICIN; KI 67 ANTIGEN; MITOMYCIN; TUMOSTERON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYSTOSCOPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

ANALYSIS OF VARIANCE; CARCINOMA; CELL DIVISION; CHI-SQUARE DISTRIBUTION; CYCLIN D1; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0345211630     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199905)188:1<44::AID-PATH320>3.0.CO;2-Q     Document Type: Article

References (33)

1. Jewett MA, Pereira G, Nijmeh P, et al. Increasing incidence, but stable mortality, of bladder cancer in Ontario. Analysis of a population sample. Urology 1991; 37: 4-7.
2. Muir CS. Cancer incidence in five continents. Classification. IARC Sci Publ 1992; 1992: 25-30.
3. Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 1992; 13: 565-574.
4. Xiong Y, Menninger J, Bach D, Ward DC. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 1992; 13: 575-584.
5. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993; 7: 812-821.
6. Quelle DE, Ashmun RA, Shurtleff SA, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993; 7: 1559-1571.
7. Jiang W, Kahn SM, Zhou P, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993; 8: 3447-3457.
8. Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994; 14: 1669-1679.
9. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994; 57: 353-361.
10. Betticher DC, Heighway J, Hasleton PS, et al. Prognostic significance of CCND1 (cyclin D1) Overexpression in primary resected non-small-cell lung cancer. Br J Cancer 1996; 73: 294-300.
11. Gillett C, Fantl V, Smith R, et al. Amplification and Overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54: 1812-1817.
12. Nakagawa H, Zukerberg L, Togawa K, Meltzer SJ, Nishihara T, Rustgi AK. Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer 1995; 76: 541-549.
13. Zukerberg LR, Yang WI, Gadd M, et al. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 1995; 8: 560-567.
14. Nishida N, Fukuda Y, Komeda T, et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994; 54: 3107-3110.
15. Yang WI, Chung KY, Shin DH, Kim YB. Cyclin D1 protein expression in lung cancer. Yonsei Med J 1996; 37: 142-150.
16. Gillett C, Smith P, Gregory W, et al. Cyclin D1 and prognosis in human breast cancer. Int J Cancer 1996; 69: 92-99.
17. Akervall JA, Michalides RJ, Mineta H, et al. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997: 79: 380-389.
18. van Diest PJ, Michalides RJ, Jannink L, et al. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol 1997; 150: 705-711.
19. Michalides R, Hageman P, van Tinteren H, et al. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996; 73: 728-734.
20. Bringuier PP, Tamimi Y, Schuuring E, Schalken J. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene 1996; 12: 1747-1753.
21. Lee CC, Yamamoto S, Morimura K, et al. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 1996; 79: 780-789.
22. Mostofi F. Histological Typing of Urinary Bladder Tumors. Geneva: World Health Organization, 1973.
23. UICC. TNM Classification of Malignant Tumours, 4th edition. Berlin: Springer-Verlag, 1992.
24. Amin MB, Young RH. Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasia. Semin Diagn Pathol 1997; 14: 84-97.
25. Moch H, Sauter G, Epper R, Mihatsch M, Gudat F, Waldman F. p53 but not erbB-2 expression is associated with rapid tumor cell proliferation in urinary bladder cancer. Hum Pathol 1994; 25: 1346-1351.
26. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
27. Spruck CHI, Ohneseit PF, Gonzalez ZM, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994; 54: 784-788.
28. Arber N, Hibshoosh H, Moss SF, et al. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996; 110: 669-674.
29. Koss L, Deitch D, Ramanathan R, Sherman A. Diagnostic value of cytology of voided urine. Acta Cytol 1985; 29: 810-816.
30. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 1996; 78: 390-395.
31. Herr HW. Bladder cancer: natural history and implications for urothelial cancer prevention. J Cell Biol Chem 1992; 16: 112.
32. Herr HW, Lamm DL, Denis L. Management of superficial bladder cancer. In: Raghavan D, Scher HI, Leibel SA, Lange PH, eds. Principles and Practice of Genitourinary Oncology. Philadelphia: Lippincott-Raven, 1997; 273-280.
33. Michalides RJ, van Veelen NM, Kristel PM, et al. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1997; 123: 497-502.